Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
578.50
-3.45 (-0.59%)
At close: Aug 14, 2026, 4:00 PM EDT
577.75
-0.75 (-0.13%)
Pre-market: Aug 17, 2026, 8:59 AM EDT
Medpace Holdings Revenue
Medpace Holdings had revenue of $707.33M in the quarter ending June 30, 2026, with 17.24% growth. This brings the company's revenue in the last twelve months to $2.78B, up 24.67% year-over-year. In the year 2025, Medpace Holdings had annual revenue of $2.53B with 19.97% growth.
Revenue (ttm)
$2.78B
Revenue Growth
+24.67%
P/S Ratio
5.80
Revenue / Employee
$448,756
Employees
6,200
Market Cap
16.15B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.53B | 421.18M | 19.97% |
| Dec 31, 2024 | 2.11B | 223.21M | 11.84% |
| Dec 31, 2023 | 1.89B | 425.85M | 29.17% |
| Dec 31, 2022 | 1.46B | 317.62M | 27.80% |
| Dec 31, 2021 | 1.14B | 216.45M | 23.38% |
| Dec 31, 2020 | 925.93M | 64.96M | 7.54% |
| Dec 31, 2019 | 860.97M | 156.38M | 22.19% |
| Dec 31, 2018 | 704.59M | 268.44M | 61.55% |
| Dec 31, 2017 | 436.15M | 14.57M | 3.46% |
| Dec 31, 2016 | 421.58M | 62.52M | 17.41% |
| Dec 31, 2015 | 359.06M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.98B |
| Labcorp Holdings | 14.35B |
| Quest Diagnostics | 11.56B |
| ICON Public Limited Company | 8.29B |
| Illumina | 4.49B |
| Mettler-Toledo International | 4.13B |
| Charles River Laboratories International | 4.00B |
| Revvity | 2.91B |
MEDP News
- 23 days ago - Medpace price target raised to $692 from $484 at RBC Capital - TheFly
- 24 days ago - Medpace price target raised to $665 from $586 at Mizuho - TheFly
- 24 days ago - Medpace price target raised to $600 from $400 at BMO Capital - TheFly
- 24 days ago - Medpace price target raised to $492 from $419 at TD Cowen - TheFly
- 24 days ago - Medpace price target raised to $624 from $547 at Baird - TheFly
- 24 days ago - Medpace price target raised to $620 from $515 at Leerink - TheFly
- 24 days ago - Medpace price target raised to $600 from $450 at Barclays - TheFly
- 24 days ago - Medpace rises 12.7% - TheFly